Linked Life Data

19248046

Source:http://linkedlifedata.com/resource/pubmed/id/19248046

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-5-4
pubmed:abstractText
This study determined the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of the oral vascular endothelial growth factor receptor (VEGFR) inhibitor, vatalanib, when administered with imatinib and hydroxyurea on a continuous daily schedule among recurrent malignant glioma patients.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-10561351, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-10786682, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-10944597, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-11016641, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-11912143, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-12097282, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-12651601, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-12727920, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-1317261, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-1322795, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-14517187, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-14561699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-14657001, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-15271251, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-15497115, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-15758009, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-15794712, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-15867205, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16033874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16288027, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16361636, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16407877, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16617323, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16636248, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16882767, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-16914578, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17215529, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17222792, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17245623, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17317837, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17947718, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-17947719, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-2358840, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-650423, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-6688572, http://linkedlifedata.com/resource/pubmed/commentcorrection/19248046-9389713
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2188-98
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
More...